Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Morepen Laboratories has informed that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, 11th November, 2021, to consider and approve the standalone and consolidated un-audited financial results of the company for the quarter and half year ended September 30, 2021.
The above information is a part of company’s filings submitted to BSE.